$CRGY

Crescent Energy price target raised to $16 from $14 at BMO Capital

BMO Capital increased its price target for Crescent Energy (CRGY) to $16 from $14, maintaining a Market Perform rating. The firm cited successful integration of Vital and improvements in breakeven costs, along with strong performance from Eagle Ford and Uinta assets.

Original reporting
Published Sep 18, 2026, 12:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 1:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crescent Energy price target raised to $16 from $14 at BMO Capital — source image
Decision brief

The 30-second read

$CRGYBullishMed
01

Why it matters

Analyst price target increase could attract new buying interest and support the stock.

02

Market read

The upgrade may influence energy sector sentiment and provide a short-term trading edge.

03

What to watch

Potential execution risk in integration and commodity price volatility.

Relevance 7/10Novelty 6/10Timing: today

Background

Crescent Energy is an independent oil and gas producer focused on the Permian Basin, Eagle Ford, and Uinta regions.

Company-level read

Ticker impact

$CRGYBullishMedium confidence
Context

BMO Capital raised Crescent Energy's price target to $16 from $14, indicating a more favorable outlook.

Expected impact

Potential modest price appreciation over the next weeks.

Evidence & confidence

Target increase reflects confidence in integration and breakeven improvements, but the absolute price change is modest.

Market effects

Positive signal for Permian and Eagle Ford oil producers.

May lift sentiment in U.S. energy sector.

Limited to U.S. energy equities.

Counterpoint

Target raise may be premature if oil prices soften.

Key entities

  • Crescent Energy

    U.S. listed oil and gas producer (ticker CRGY).

  • BMO Capital

    Investment bank that issued the price target raise.

Related articles

$CVXMed

Sullivan: Wall Street admits it doesn't know where oil is headed. There's one stock they do agree on

JPMorgan admits uncertainty about oil market's direction due to Iran conflict, with key economic indicators crossed. Analysts highlight Chevron (CVX) as a top pick, with Goldman Sachs raising its target to $240. BP (BP) is also noted for its evolving strategy and potential. Smaller cap Crescent Energy (CRGY) is recommended by Truist with a $19 target. Refiners like Valero (VLO), Marathon Petroleum (MPC), and others are near record highs.

$CRGYMed

CRGY Raises 2026 Outlook as Permian Synergies Expand Free Cash Flow

Crescent Energy (CRGY) raised its 2026 production outlook to 327-335k barrels per day, up from 320-335k, while keeping capital spending unchanged. It also lowered operating cost guidance to $11-$12 per barrel. The company tripled its Permian synergy target to $250-$300 million, citing faster-than-expected savings. Management expects over $1 billion in free cash flow in 2026.

$CRGYMed

Crescent Energy Bumps Up Production Forecast

Crescent Energy Co raised its full-year production forecast to 327,000-335,000 boe/d, with 40-42% oil, citing stronger first-half performance. Q2 output fell to 335,000 boe/d from 341,000 in Q1. Q2 net profit was $494m, adjusted profit $263m, and record adjusted EBITDAX $798m. Dividend $0.12 and $336m buyback remaining.